CALGARY, AB, Nov. 4, 2021 /CNW/ - Universal Ibogaine Inc.
(TSXV: IBO) ("Universal Ibogaine", "UI" or the "Company"), a life
sciences company with a mission to research and deliver medicalized
ibogaine-centered addiction care, is pleased to announce an
expansion of its Executive Team and welcomes addiction treatment
and clinic operations veteran Dr Ian
Rabb as Chief Clinics Officer effective November 15, 2021.
Dr Ian Rabb
Dr Ian Rabb is one of the most
recognized and respected leaders in Addiction Treatment in
Canada today. Dr.
Ian Rabb is a certified
Interventionist and addictions specialist who has helped thousands
of people overcome addiction. In his 20 years of sobriety, he has
founded Two Ten Recovery and Destiny
House — Winnipeg's only
sober living housing organization. Ian was the visionary
founding member of Aurora Recover Centre in Gimli Manitoba and most recently held the
position of Director of Business Development at Edgewood Health
Network, Canada's only national
addiction treatment center brand. Prior to his work in
addiction treatment Ian was a practicing Doctor of Optometry.
Ian has served on the board of directors of the Addictions
Foundation of Manitoba and
Tamarack Rehab. He was Chair of a forum for VOICES, which
provides healthy, welcoming community centers where transitioning
foster youth and adults can have access to comprehensive housing,
education, employment, and wellness services. Ian served on the
inaugural board of End Homelessness Winnipeg and sat on the
Community Advisory Board for federal The Homelessness Partnering
Strategy. Ian was also appointed to a federal, provincial and
municipal illicit drug task force in 2019. He has further played an
active role on the board of the Jewish Child and Family Services
and performed fund raising roles for the Children's Hospital
Foundation, and the Health Science Centre Foundation. Ian was
nominated as a finalist for the national Scotiabank Game Changers
(celebrating local heroes) in 2012; was awarded the Queens
Diamond Jubilee medal in 2012; and
in 2016, Ian was chosen and honoured as a "Manitoba Hero" for his
tireless work in service of Manitobans.
In his own words Ian says "In my 20 years in the addiction
recovery business I have not seen anything that has the power of
Ibogaine to disrupt the devastating effects of addiction and help
change the course of peoples lives who have been living with
addiction. The opportunity to join the leadership of
Universal Ibogaine, to guide in their mission to advance the
science of addiction treatment to a level we have never seen before
provided an opportunity to be of service that I could not
refuse. I am so grateful for the opportunity to lead the
clinic operations and development area of Universal
Ibogaine."
Dr Rami Batal CEO of Universal Ibogaine shared his
enthusiasm for this significant addition to the team "Universal
Ibogaine has two main pillars of business: the development of
medicines for addiction with the medicalization of ibogaine being a
central feature, and the development of state-of-the-art holistic
addiction treatment centers. Today we have taken a
significant step forward in the realization of best-in-class
holistic treatment for addiction. With our recent operating
clinic acquisition and the addition of Ian to the leadership team
we are confidently moving towards our goal of creating the gold
standard for addiction treatment. We intend to optimize the
treatment program at our Kelburn facility then roll out in future
clinics, directly or through partnerships in Canada, USA
and Internationally."
Dr Alberto Sola Co-Founder of Universal
Ibogaine indicated "We know ibogaine works to disrupt
addition and facilitate rapid and relatively pain free detox from
opioids and other drugs. As we work through the regulatory
process with Health Canada, we can develop a best-in-class holistic
long-term disease management model, customized to the needs of the
individual. The protocol will be based first on conventional
detox and treatment, then using ibogaine as it becomes
approved. There is no one more experienced or competent in
that program development than Dr Ian
Rabb."
Kelburn Mental Health and Addiction Treatment
Facility
Dr Ian Rabb will
take the helm at the Universal Ibogaines recently acquired
addiction treatment facility located outside of Winnipeg, Manitoba. Ian's first step
will be to add conventional medical detox into the treatment
offering at Kelburn. Next, he aims to develop innovative,
unique individualized treatment programs with a menu of post detox
treatment modalities including various psychotherapy models,
evidence based nuevo treatments that can include other plants
medicines, nutrition, exercise, and time in nature facilitated by
Kelburn's pristine natural setting. From there Ian looks to
incorporate indigenous wisdom and healing facilitated by local
first nations leaders.
About Universal Ibogaine Inc.
UI is a life sciences company, with a goal to develop a platform
of addiction treatment clinics, which may eventually use ibogaine
as a primary modality for the interruption and ideally cessation of
addictions to primarily opioids such as oxycodone, heroin,
fentanyl, as well as alcohol, cocaine, and other
stimulants.
UI separately plans to clinically develop ibogaine, a natural
plant substance, as an authorized addiction interruption medicine
for the treatment of Opioid Use Disorder. A Clinical Trial
Application to Health Canada is being developed to undertake
clinical trials in Canada, aimed
at proving the safety and efficacy of the use of ibogaine for this
purpose. In the longer term, UI plans to introduce ibogaine
into the addiction treatment protocols to be used in its' future
facilities.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES
PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX
VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR
ACCURACY OF THIS RELEASE.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING
STATEMENTS
This news release may contain forward-looking statements and
information. Forward-looking information is frequently
characterized by words such as "plans", "expect", "project",
"intend", "will", "believe", "anticipate", "estimate", "scheduled",
"potential", or other similar words, or statements that certain
events or conditions "may", "should" or "could" occur. The
forward-looking statements and information are based on certain key
expectations and assumptions made by UI. Although UI
believes that the expectations and assumptions on which the
forward-looking statements are based are reasonable, undue
reliance should not be placed on the forward-looking statements
because UI can give no assurance that they will prove to be
correct.
Since forward-looking statements address future events and
conditions, by their very nature they involve inherent risks and
uncertainties. Actual results could differ materially from those
currently anticipated due to a number of factors and risks, which
include, but are not limited to, risks that required regulatory
approvals are not obtained. The reader is cautioned that
assumptions used in the preparation of such information, although
considered reasonable by UI at the time of preparation, may prove
to be incorrect and readers are cautioned not to place undue
reliance on forward-looking information, which speaks only to
conditions as of the date hereof. UI does not undertake any
obligation to release publicly any revisions to forward-looking
information contained herein to reflect events or circumstances
that occur after the date hereof or to reflect the occurrence of
unanticipated events, except as may be required under applicable
securities laws.
Related Links
https://universalibogaine.com
SOURCE Universal Ibogaine Inc.